CXCL10 and systemic sclerosis: In agreement with findings in other chronic inflammatory conditions, such as type I diabetes [15], systemic sclerosis [19], and autoimmune thyroiditis [26], we found that the CXCL10 serum levels are significantly increased in untreated CD patients.